RecruitingHIV InfectionsAge
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Sponsor: Hennepin Healthcare Research Institute
You may qualify if…
- ✓ Age\>=18 years
- ✓ HIV Diagnosis
- ✓ On Antiretroviral Therapy with HIV Viral Load\<200 within last year
You may not qualify if…
- ✕ Other significant immunosuppressing condition
- ✕ Age\< 18 years
- ✕ Pregnancy (at enrollment)
- ✕ Contraindication to pneumococcal vaccination
- ✕ Known contraindication to non-clinical blood draws (severe anemia last hemoglobin \<8g/dl)
- ✕ Subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.
- ✕ Adults unable to consent
- ✕ Individuals with impaired ability to consent
Where it's recruiting
Minnesota
Minneapolis
Source: ClinicalTrials.gov · NCT06514547 · last updated 2025-06-12